Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, saying that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-26T14:44:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:23:42.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:12:59.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, with an error header visible. This indicates that the study record is currently inaccessible and the content is replaced by an access-denied message.
    Difference
    20%
    Check dated 2026-09-21T14:43:17.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This reflects a minor software update to the page rather than changes to the trial details.
    Difference
    0.1%
    Check dated 2026-08-29T23:45:21.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new Study Protocol and Statistical Analysis Plan PDF was added to the Study Documents section, provided by the University of Pittsburgh; the file size is 0.73 MB.
    Difference
    59%
    Check dated 2026-08-15T23:56:13.000Z thumbnail image

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.